Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells
β Scribed by Hongyan Gu; Shuyun Rao; Jie Zhao; Jia Wang; Rong Mu; Jingjing Rong; Lei Tao; Qi Qi; Qidong You; Qinglong Guo
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 413 KB
- Volume
- 135
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
bcl-2 expression is often associated with poor prognosis in several types of tumors; however, the role of this molecule in breast cancer is still controversial. We found earlier that over-expression of bcl-2 in a human breast-cancer cell line (MCF7 ADR ) enhances its tumorigenicity and metastatic po
Somatostatin (SST) analogs inhibit tumor cell growth by exerting direct anti-proliferative effects with cytostatic (growth arrest) or cytotoxic (apoptosis) consequences. The SST analog SMS 201-995 (octreotide, OCT) inhibits growth of MCF-7 human breast adenocarcinoma cells, which express multiple SS
## Abstract Human MCFβ7 breast cancer cells are relatively resistant to conventional chemotherapy due to the lack of caspaseβ3 activity. We reported recently that roscovitine (ROSC), a potent cyclinβdependent kinase 2 inhibitor, arrests human MCFβ7 breast cancer cells in the G~2~ phase of the cell